Alnylam Pharmaceuticals
ALNY
#540
Rank
C$61.20 B
Marketcap
C$463.28
Share price
0.47%
Change (1 day)
14.66%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company